Literature DB >> 8406987

Abnormalities affecting the APC and MCC tumour suppressor gene loci on chromosome 5q occur frequently in gastric cancer but not in pancreatic cancer.

A B McKie1, M I Filipe, N R Lemoine.   

Abstract

Abnormalities affecting tumour suppressor genes on chromosome 5q21 are increasingly recognised as important in the pathogenesis of a variety of human cancers, particularly of the gastrointestinal tract. We have examined a series of gastric and pancreatic cancers from European patients for loss of heterozygosity (LOH) of markers within and around the APC and MCC genes on chromosome 5q21 using restriction fragment length polymorphism and polymerase chain reaction techniques. We find that LOH of the APC and MCC genes is particularly frequent in gastric cancers of diffuse type, but very infrequent in pancreatic cancers. We have also used single-strand conformational polymorphism to screen for abnormalities of the sequence of the APC and MCC genes in a panel of pancreatic cancer cell lines. Our results suggest that there are distinct differences in the molecular pathogenesis of gastric and pancreatic cancer and that abnormalities of APC and MCC may be involved particularly in the diffuse type of gastric cancer.

Entities:  

Mesh:

Year:  1993        PMID: 8406987     DOI: 10.1002/ijc.2910550414

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  16 in total

1.  K-ras mutations and allelic loss at 5q and 18q in the development of human pancreatic cancers.

Authors:  K Sugio; K Molberg; J Albores-Saavedra; A K Virmani; Y Kishimoto; A F Gazdar
Journal:  Int J Pancreatol       Date:  1997-06

2.  Differences in genomic instability between intestinal- and diffuse-type gastric cancer.

Authors:  Matti Vauhkonen; Hanna Vauhkonen; Antti Sajantila; Pentti Sipponen
Journal:  Gastric Cancer       Date:  2005       Impact factor: 7.370

Review 3.  The use of molecular technology in the differentiation of pancreatic cancer and chronic pancreatitis.

Authors:  S R Bramhall
Journal:  Int J Pancreatol       Date:  1998-04

4.  Genetic progression and divergence in pancreatic carcinoma.

Authors:  M Yamano; H Fujii; T Takagaki; N Kadowaki; H Watanabe; T Shirai
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

5.  Mutation analysis of APC gene in gastric cancer with microsatellite instability.

Authors:  Dian-Chun Fang; Yuan-Hui Luo; Shi-Ming Yang; Xiao-An Li; Xian-Long Ling; Li Fang
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

Review 6.  Molecular oncology in pancreatic cancer.

Authors:  S Gansauge; F Gansauge; H G Beger
Journal:  J Mol Med (Berl)       Date:  1996-06       Impact factor: 4.599

7.  APC promoter is frequently methylated in pancreatic juice of patients with pancreatic carcinomas or periampullary tumors.

Authors:  Mireia M Ginesta; Zamira Vanessa Diaz-Riascos; Juli Busquets; Núria Pelaez; Teresa Serrano; Miquel Àngel Peinado; Rosa Jorba; Francisco Javier García-Borobia; Gabriel Capella; Joan Fabregat
Journal:  Oncol Lett       Date:  2016-07-15       Impact factor: 2.967

Review 8.  Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer.

Authors:  Gen Tamura
Journal:  World J Gastroenterol       Date:  2006-01-14       Impact factor: 5.742

9.  Lack of mutations of the adenomatous polyposis coli gene in oesophageal and gastric carcinomas.

Authors:  S Ogasawara; C Maesawa; G Tamura; R Satodate
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

10.  Allelotype analysis of adenocarcinoma of the gastric cardia.

Authors:  C M Gleeson; J M Sloan; J A McGuigan; A J Ritchie; J L Weber; S E Russell
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.